Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen to Make Sequence Analysis Software Free for Nonprofit Labs

NEW YORK, Sept. 28 (GenomeWeb News) - Invitrogen has created a Vector NTI Open Access policy and the online Vector NTI User Community in conjunction with the release of Vector NTI Advance 10, the latest version of its NTI sequence analysis software, the firm said today.


According to the company, the Open Access policy will enable researchers in not-for-profit laboratories to apply for free, annual, and renewable licenses of Vector NTI. The User Community is designed to serve as an online meeting place for researchers to acquire the latest versions of the software, obtain technical resources, and communicate with Invitrogen and other users, Invitrogen said.


Greg Lucier, chairman and CEO of Invitrogen, said the company anticipates "having tens of thousands of users in the academic, government and research institutions take advantage of our Open Access policy."

Invitrogen said that the Wellcome Trust Sanger Institute and The Scripps Research Institute are both Open Access participants.


GenomeWeb News' sister publication BioInform reported on the developments surrounding Vector NTI two weeks ago.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.